Fabian Kiessling
Molecular Biology · 2012–2019
A researcher in the Science corpus: 5 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 72 citations into it
- Biomedical Engineering — 52 citations into it
Whom Fabian Kiessling trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- Rakesh K. Jain (in Molecular Biology)
Papers from Fabian Kiessling's perspective
Ordered by how strongly the researchers Fabian Kiessling trusts endorse each paper. Same corpus, a different order for every researcher.
- Pathology: Cancer cells compress intratumour vessels (Nature)
- Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. (Cancer Research)
- Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors (Proceedings of the National Academy of Sciences of the United States of America)
- Delivering nanomedicine to solid tumors (Nature Reviews Clinical Oncology)
- Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers. (Journal of Clinical Oncology)
- Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors (Proceedings of the National Academy of Sciences of the United States of America)
- Ligand-targeted therapeutics in anticancer therapy (Nature Reviews. Cancer)
- Openings between defective endothelial cells explain tumor vessel leakiness. (American Journal of Pathology)
- Vascular Normalization by Vascular Endothelial Growth Factor Receptor 2 Blockade Induces a Pressure Gradient Across the Vasculature and Improves Drug Penetration in Tumors (Cancer Research)
- The hallmarks of cancer (RNA Biology)
Their papers
- MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1 (2014) — 624 citations
- Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress. (2012) — 1,266 citations
- Smart cancer nanomedicine: Strategic directions to improve translation and exploitation (2019) — 966 citations
- Iron Oxide Nanoparticles: Diagnostic, Therapeutic and Theranostic Applications (2019) — 938 citations
- Tumor Targeting via EPR: Strategies to Enhance Patient Responses (2018) — 1,055 citations